LYEL logo

LYEL
Lyell Immunopharma Inc

436
Mkt Cap
$460.35M
Volume
54,245.00
52W High
$45.00
52W Low
$7.65
PE Ratio
-1.37
LYEL Fundamentals
Price
$20.83
Prev Close
$19.73
Open
$20.03
50D MA
$22.30
Beta
1.59
Avg. Volume
87,470.17
EPS (Annual)
-$16.06
P/B
1.78
Rev/Employee
$223.60
$329.90
Loading...
Loading...
News
all
press releases
Lyell Immunopharma (NASDAQ:LYEL) Shares Gap Down - Here's What Happened
Lyell Immunopharma (NASDAQ:LYEL) Shares Gap Down - Here's What Happened...
MarketBeat·8d ago
News Placeholder
More News
News Placeholder
Lyell Immunopharma (NASDAQ:LYEL) Upgraded by Wall Street Zen to "Hold" Rating
Wall Street Zen upgraded Lyell Immunopharma from a "sell" rating to a "hold" rating in a research note on Saturday...
MarketBeat·14d ago
News Placeholder
Lyell Immunopharma, Inc. (NASDAQ:LYEL) Sees Large Increase in Short Interest
Lyell Immunopharma, Inc. (NASDAQ:LYEL - Get Free Report) was the recipient of a significant growth in short interest in March. As of March 31st, there was short interest totaling 1,138,296 shares, a...
MarketBeat·15d ago
News Placeholder
Lyell Immunopharma (NASDAQ:LYEL) Shares Down 4% - Should You Sell?
Lyell Immunopharma (NASDAQ:LYEL) Trading Down 4% - Time to Sell...
MarketBeat·17d ago
News Placeholder
Lyell Immunopharma (NASDAQ:LYEL) Stock Price Up 6.9% - Should You Buy?
Lyell Immunopharma (NASDAQ:LYEL) Trading Up 6.9% - Still a Buy...
MarketBeat·18d ago
News Placeholder
Lyell Immunopharma, Inc. (NASDAQ:LYEL) Receives Consensus Recommendation of "Hold" from Analysts
Shares of Lyell Immunopharma, Inc. (NASDAQ:LYEL - Get Free Report) have been assigned a consensus recommendation of "Hold" from the five ratings firms that are presently covering the stock, Marketbeat Ratings reports. Two analysts have rated the stock with a sell rating and three have assigned a b...
MarketBeat·22d ago
News Placeholder
Needham & Company LLC Begins Coverage on Lyell Immunopharma (NASDAQ:LYEL)
Needham & Company LLC started coverage on shares of Lyell Immunopharma in a research note on Friday. They issued a "buy" rating and a $44.00 price objective on the stock...
MarketBeat·22d ago
News Placeholder
Lyell Immunopharma (NASDAQ:LYEL) Cut to Strong Sell at Zacks Research
Zacks Research downgraded Lyell Immunopharma from a "hold" rating to a "strong sell" rating in a report on Tuesday...
MarketBeat·23d ago
News Placeholder
Lyell Immunopharma (NASDAQ:LYEL) Trading Up 9.2% - Time to Buy?
Lyell Immunopharma (NASDAQ:LYEL) Trading 9.2% Higher - Time to Buy...
MarketBeat·1mo ago
News Placeholder
Lyell Immunopharma (NASDAQ:LYEL) Lowered to Sell Rating by Wall Street Zen
Wall Street Zen cut shares of Lyell Immunopharma from a "hold" rating to a "sell" rating in a report on Saturday...
MarketBeat·1mo ago
<
1
2
...
>

Latest LYEL News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.